Stock Ratings / Health Care / XTNT / dividends

TELA (39) CVRX (31) SNWV (52) SRTS (41) ⌘ Pro Terminal →

Xtant Medical Holdings Inc. (XTNT) Dividend Safety Gauge & 10-Year DRIP Compounder

$0.29 +1.54% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $0.29

Xtant Medical Holdings Inc. (XTNT) carries a Roarable Rating of C (Hold) with 65/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

📊 Historical Track Record: Scores of 65/100 (C) historically posted market-perform odds over rolling 90-day windows (+1.3% avg 90D alpha vs SPY) →

ROARABLE C • HOLD / WATCH Cap $40.7M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on XTNT Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is XTNT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-02, Xtant Medical Holdings Inc. (NYSE: XTNT) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 65/100 at a spot price of $0.29 (+1.54% 1D, market cap $40.7M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 12/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 16/20. Across 1016 tracked Health Care issuers, XTNT ranks #130 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does XTNT compare to TELA and CVRX in the Health Care sector?

▼

Within the Health Care sector (Medical/Dental Instruments), XTNT carries a Roarable C (65/100 RQD), trailing P/E of N/A, gross margin of 62.9%, and ROIC of 12.8%. By comparison, TELA (TELA Bio Inc.) holds a D- grade (39/100 RQD, P/E N/A, ROIC -35.0%, cap $41.5M) and CVRX (CVRx Inc.) posts a E grade (31/100 RQD, P/E N/A, ROIC -35.0%, cap $38.0M). Among the 5-stock peer group, SNWV leads on earnings multiple (3.8x) while SNWV leads on capital efficiency (67.3% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for XTNT?

▼

Per XTNT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001453593), Xtant Medical Holdings Inc. generated $133.9M in revenue (+14.2% YoY), $5.0K in net income, and $10.2M in free cash flow against $94.1M in total assets and $11.0M in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $0.29 (+0.09%)🧬 Cannibal Buyback (-2.36% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 7.6% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 65/100 (C) historically posted market-perform odds over rolling 90-day windows (+1.3% avg 90D alpha vs SPY • 55.6% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERHOLD / WATCH • C

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw C+ · Rk C

Each axis scored 0–20

12M PRICE TARGET CONE+3.4% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for XTNT)Realized 20D OHLCV Swing Band: ±12.3%

Deterministic 5-Pillar Attribution (65/100 Composite)

🔍 WHY XTNT SCORES 65/100 (C) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Insider Conviction & Share Dilution+16/20 pts (25% of score)

SEC Form 4 / 13F Thermometer: 80% Net Buy • Cannibal Buyback (-2.36% YoY Shares)

▲ #2 Bullish Driver: Macro Regime Fit+13/20 pts (20% of score)

FRED Regime × Technicals: 3% of 52W Range • RSI-14 at 40.7 (NEUTRAL RANGE)

▼ #1 Drag / Risk Factor: SEC 10-K Forensic Risk12/20 pts (-8 pt drag)

Balance-sheet & 10-K footnote risk deducts 8 pts from forensic ceiling

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade B$0.33-12.1% Next Q

Q2 (-2Q)

Grade B$0.29-3.4% Next Q

Q3 (-1Q)

Grade B-$0.28+3.6% Next Q

Current

Grade C$0.29+1.3% Hist 90D α

Trajectory: B (73) → C (65)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the XTNT Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 65/100 (C) score, XTNT faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.36% YoY Shares) — any gross margin slip below 60.4% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($0.33) or 200D SMA ($0.46) invalidates the momentum regime and cuts Target Base ($0.30) toward Bear Floor ($0.23).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $XTNT• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “XTNT Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 65%NO 35%Trade / Inspect Odds →

CASH DIVIDEND + BUYBACK YIELD

1.8% Total Yield

0% Cash ($0.00/yr) + 1.8% Buybacks

PAYOUT SAFETY SPEEDOMETER

74/100 • REINVESTING IN GROWTH + BUYBACKS

FREE CASH FLOW PAYOUT RATIO

0% (100% Reinvested)

Retains cash flow for R&D and share repurchases

INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (9.6% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $25,010

Est. Year-10 Shareholder Yield: $450/yr

Starting Investment: $10,000

Compounding Horizon: 10 Years

$11.0K

Yr 1

$12.0K

Yr 2

$13.2K

Yr 3

$14.4K

Yr 4

$15.8K

Yr 5

$17.3K

Yr 6

$19.0K

Yr 7

$20.8K

Yr 8

$22.8K

Yr 9

$25.0K

Yr 10

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Cash-Flow & Quality Compounder Desk

Cash-Fortress Compounders: Auditing Free Cash Flow & Yield Safety in XTNT & A-Rated Leaders

✓12-month Bull/Base/Bear fair-value walkthrough on XTNT and its top sector peer
✓Top Roarable A-Rated cash compounders with verified executive & 13F accumulation
✓Includes nightly RQD rating-change & forensic signal email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

XTNT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -48.21%🛡️ HOLDING TREND SUPPORT

2026-11-02O $0.29H $0.29L $0.29C $0.29VOL 38.5K

RES: $0.43SUP: $0.27SMA50: $0.33SMA200: $0.46

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

XTNT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 XTNT Butterfly Map → + Track XTNT →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

-15.0%/yr Implied 5Y Growth

vs. +14.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on XTNT today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for XTNT. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for XTNT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (XTNT)

Health Care Rank #130 of 1016 ⚔️ TELA vs XTNT Full Matrix →

1. Head-to-Head Health Care Peer Comparison (XTNT vs. TELA, CVRX, SNWV, SRTS)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Xtant Medical Holdings Inc. (XTNT) ranks #130 by composite RQD confidence (65/100, grade C) and #773 by equity capitalization ($40.7M). Within this direct 5-issuer industry benchmark cohort, SNWV leads on earnings valuation at 3.8x trailing P/E, while SNWV leads on capital efficiency and profitability with 67.3% ROIC and 77.1% gross margin. XTNT currently leads its immediate peer cohort in composite quantitative strength at 65/100 (C).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
XTNT ACTIVE Xtant Medical Holdings Inc.	C	65/100	—	62.9%	12.8%	+1.54%	$40.7M	Benchmark Subject
TELA TELA Bio Inc.	D-	39/100	—	67.7%	-35.0%	-5.74%	$41.5M	/tela-vs-xtnt →
CVRX CVRx Inc.	E	31/100	—	85.3%	-35.0%	+1.79%	$38.0M	/cvrx-vs-xtnt →
SNWV SANUWAVE Health Inc.	D+	52/100	3.8x	77.1%	67.3%	0.00%	$45.3M	/snwv-vs-xtnt →
SRTS Sensus Healthcare Inc.	D-	41/100	—	43.2%	-31.3%	-1.77%	$45.6M	/srts-vs-xtnt →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001453593

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Xtant Medical Holdings Inc. (XTNT) reported GAAP revenue of $133.9M (+14.2% vs. FY2024 revenue of $117.3M , and +46.7% cumulative change since FY2023) , GAAP net income of $5.0K, operating cash flow of $12.5M, and free cash flow of $10.2M (+163.5% YoY). On the balance sheet, XTNT closed FY2025 with $94.1M in total assets against $11.0M in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 9/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$133.9M	$5.0K	$12.5M	$10.2M	$94.1M	$11.0M
FY2024 (FY)	2024-12-31	$117.3M	-$16.4K	-$11.9M	-$16.0M	$93.8M	$22.0M
FY2023 (FY)	2023-12-31	$91.3M	$660	-$9.5M	-$9.5M	—	—

3. XTNT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is XTNT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does XTNT compare to TELA and CVRX in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for XTNT?

Where is XTNT trading relative to its 50-day, 200-day, and 52-week technical levels?

XTNT last traded at $0.29 (+1.54% on volume of 38,463 shares), positioning the stock -12.12% below its 50-day simple moving average ($0.33) and -36.96% below its 200-day simple moving average ($0.46). Across its 52-week range of $0.27 to $0.95, XTNT sits at the 2.9% percentile with a 14-day RSI of 40.7 (NEUTRAL RANGE) and an implied next-earnings move of ±12.3% ($1.00 to $0.33).

XTNT Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Does XTNT pay a dividend and is it safe?

Xtant Medical Holdings Inc. (XTNT) offers a 0% cash dividend yield ($0.00 annualized) and 1.8% total shareholder yield including buybacks. Roarable rates its payout coverage as REINVESTING IN GROWTH + BUYBACKS.

Direct Sub-Reports: XTNT RQD Cockpit XTNT 12M Forecast XTNT Earnings & Move XTNT Dividends & DRIP XTNT Insiders & 13F XTNT Whale Options XTNT Profit Sankey XTNT News & Why